Cargando…

Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes

OBJECTIVES: The study aimed to investigate the clinical characteristics and antibiotic management, as well as independent indicators for survival within 30 days for Escherichia coli bloodstream infection (BSI) in liver cirrhosis. RESULTS: Hospital-acquired BSI accounted for 60.07%, with prolonged ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Bo, Bi, Jingfeng, Wu, Dan, Zhao, Peng, Shi, Lei, Xie, Yangxin, Zhang, Xin, Xu, Zhe, Liu, Suxia, Wang, Xinhua, Li, Xiaoxi, Wang, Fusheng, Qin, Enqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254670/ https://www.ncbi.nlm.nih.gov/pubmed/30515269 http://dx.doi.org/10.18632/oncotarget.23200

Ejemplares similares

Investigation on outcomes and bacterial distributions of liver cirrhosis patients with gram-negative bacterial bloodstream infection
por: Xie, Yangxin, et al.
Publicado: (2017)

Bacterial distributions and prognosis of bloodstream infections in patients with liver cirrhosis
por: Xie, Yangxin, et al.
Publicado: (2017)

Nosocomial and Community-Acquired Spontaneous Bacterial Peritonitis in patients with liver cirrhosis in China: Comparative Microbiology and Therapeutic Implications
por: Shi, Lei, et al.
Publicado: (2017)

Corrigendum: Nosocomial and Community-Acquired Spontaneous Bacterial Peritonitis in patients with liver cirrhosis in China: Comparative Microbiology and Therapeutic Implications
por: Shi, Lei, et al.
Publicado: (2017)

Microbiological Characteristics and Antibiotic Sensitivity in Patients with Nosocomial Spontaneous Bacterial Peritonitis Caused by Escherichia coli: A Multicenter Study
por: Tu, Bo, et al.
Publicado: (2020)

Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Patients with Liver Cirrhosis
por: Chen, Wen-Chi, et al.
Publicado: (2021)

Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections
por: Kim, Yong Chan, et al.
Publicado: (2023)

Analysis of early-onset bloodstream infection due to Escherichia coli infection in premature babies
por: Chen, I-Lun, et al.
Publicado: (2017)

Homologous Escherichia coli Identified in Cerebrospinal Fluid and Bloodstream
por: Shi, Qingmiao, et al.
Publicado: (2021)

Risk Factors for Bloodstream Infections Due to ESBL-Producing Escherichia coli, Klebsiella spp., and Proteus mirabilis
por: Vance, Mary Kathryn, et al.
Publicado: (2023)

Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis
por: Bi, Jingfeng, et al.
Publicado: (2017)

Escherichia coli bloodstream infection preceding the diagnosis of rectal carcinoma
por: Thoma, Reto, et al.
Publicado: (2018)

Escherichia albertii isolated from the bloodstream of a patient with liver cirrhosis in China: A case report
por: Liu, Qian, et al.
Publicado: (2023)

Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanxi, China
por: Zhang, Yanjun, et al.
Publicado: (2021)

Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection
por: Duan, Jinyan, et al.
Publicado: (2016)

Appropriate Treatment for Bloodstream Infections Due to Carbapenem-Resistant Klebsiella pneumoniae and Escherichia coli: A Nationwide Multicenter Study in Taiwan
por: Lin, Yi-Tsung, et al.
Publicado: (2018)

Marked increase in incidence for bloodstream infections due to Escherichia coli, a side effect of previous antibiotic therapy in the elderly
por: van der Mee-Marquet, Nathalie L., et al.
Publicado: (2015)

210. Evaluating the Costs of Escherichia coli Bloodstream Infections: A Population-Based Cohort Study
por: King, Teagan, et al.
Publicado: (2023)

Escherichia coli Eyelid Abscess in a Patient with Alcoholic Cirrhosis
por: Stratton, Matthew, et al.
Publicado: (2015)

Colistin Resistance in Escherichia coli Isolates From Patients With Bloodstream Infection in Korea
por: Kim, Young Ah, et al.
Publicado: (2017)

The bacterial genetic determinants of Escherichia coli capacity to cause bloodstream infections in humans
por: Burgaya, Judit, et al.
Publicado: (2023)

Molecular Characteristics of Escherichia coli Causing Bloodstream Infections During 2010–2015 in a Tertiary Hospital, Shanghai, China
por: Li, Dan, et al.
Publicado: (2021)

Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible Escherichia coli: A Missed Opportunity for De-Escalation of Therapy
por: Carlisle, Leah, et al.
Publicado: (2018)

2290. Carbapenem vs. Piperacillin–tazobactam Definitive Therapy for Patients with Bloodstream Infections Due to Ceftriaxone Not Susceptible Escherichia coli or Klebsiella species
por: MacVane, Shawn H, et al.
Publicado: (2019)

Emphysematous Osteomyelitis due to Escherichia coli
por: Lee, Jinhee, et al.
Publicado: (2017)

Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream
por: Samet, A., et al.
Publicado: (2013)

Population Dynamics of Escherichia coli Causing Bloodstream Infections over Extended Time Periods
por: Pitout, Johann D. D.
Publicado: (2021)

Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study
por: MacKinnon, Melissa C., et al.
Publicado: (2021)

The Characteristics of Extended-Spectrum β-Lactamases (ESBLs)-Producing Escherichia coli in Bloodstream Infection
por: Li, Rongrong, et al.
Publicado: (2023)

Economic Burden of Patients with Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli
por: Wang, Yuan, et al.
Publicado: (2020)

Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China
por: Wang, Su, et al.
Publicado: (2016)

Complete Genome Sequences of Four Escherichia coli ST95 Isolates from Bloodstream Infections
por: Stephens, Craig M., et al.
Publicado: (2015)

Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics
por: Daga, Ana Paula, et al.
Publicado: (2019)

Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection
por: Mac Aogáin, Micheál, et al.
Publicado: (2016)

A prospective study of Escherichia coli bloodstream infection among adolescents and adults in northern Tanzania
por: Madut, Deng B, et al.
Publicado: (2020)

Genome-based characterization of Escherichia coli causing bloodstream infection through next-generation sequencing
por: Paramita, Rafika Indah, et al.
Publicado: (2020)

Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019
por: Bai, Changsen, et al.
Publicado: (2022)

Bloodstream infection by mcr-1-harboring Escherichia coli in a cancer patient in southern Brazil
por: Lorenzoni, Vinícius Victor, et al.
Publicado: (2018)

Temporal dynamics of genetically heterogeneous extended-spectrum cephalosporin-resistant Escherichia coli bloodstream infections
por: Shropshire, William C., et al.
Publicado: (2023)

Spatial features for Escherichia coli genome organization
por: Xie, Ting, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sjobaasaqg310nsrf1hic2i509